These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17333203)

  • 21. Prostate cancer nomograms are superior to neural networks.
    Karakiewicz PI; Chun FK; Briganti A; Perrotte P; McCormack M; Bénard F; Valiquette L; Graefen M; Saad F
    Can J Urol; 2006 Apr; 13 Suppl 2():18-25. PubMed ID: 16672124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and internal validation of preoperative transition zone prostate cancer nomogram.
    Steuber T; Chun FK; Erbersdobler A; Briganti A; Haese A; Graefen M; Schlomm T; Valiquette L; Huland H; Karakiewicz PI
    Urology; 2006 Dec; 68(6):1295-300. PubMed ID: 17141836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Information content of five nomograms for outcomes in prostate cancer.
    Bismar TA; Humphrey P; Vollmer RT
    Am J Clin Pathol; 2007 Nov; 128(5):803-7. PubMed ID: 17951203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contemporary concept of significant versus insignificant prostate cancer.
    Ploussard G; Epstein JI; Montironi R; Carroll PR; Wirth M; Grimm MO; Bjartell AS; Montorsi F; Freedland SJ; Erbersdobler A; van der Kwast TH
    Eur Urol; 2011 Aug; 60(2):291-303. PubMed ID: 21601982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
    Nam RK; Toi A; Klotz LH; Trachtenberg J; Jewett MA; Loblaw A; Pond GR; Emami M; Sugar L; Sweet J; Narod SA
    Can J Urol; 2006 Apr; 13 Suppl 2():2-10. PubMed ID: 16672122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population.
    Wang Y; Xie S; Shangguan X; Pan J; Zhu Y; Xin Z; Xu F; Shao X; Fan L; Sha J; Liu Q; Dong B; Xue W
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1157-1166. PubMed ID: 28283782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nomogram as predictive model in clinical practice].
    Ohori Tatsuo Gondo And Riu Hamada M; Gondo T; Hamada R
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):901-6. PubMed ID: 19542708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
    Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancer.
    Murray NP; Reyes E; Fuentealba C; Orellana N; Jacob O; Badilla S
    Urol Oncol; 2015 May; 33(5):203.e19-25. PubMed ID: 25746939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with (125) iodine brachytherapy.
    Kaplan A; German L; Chen J; Matzkin H; Mabjeesh NJ
    BJU Int; 2012 Jun; 109(11):1661-5. PubMed ID: 22115188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
    Chun FK; Haese A; Ahyai SA; Walz J; Suardi N; Capitanio U; Graefen M; Erbersdobler A; Huland H; Karakiewicz PI
    Cancer; 2008 Aug; 113(4):701-9. PubMed ID: 18553365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
    Karakiewicz PI; Benayoun S; Kattan MW; Perrotte P; Valiquette L; Scardino PT; Cagiannos I; Heinzer H; Tanguay S; Aprikian AG; Huland H; Graefen M
    J Urol; 2005 Jun; 173(6):1930-4. PubMed ID: 15879784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
    Chun FK; Graefen M; Briganti A; Gallina A; Hopp J; Kattan MW; Huland H; Karakiewicz PI
    Eur Urol; 2007 May; 51(5):1236-40; discussion 1241-3. PubMed ID: 16945477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.
    Abdollah F; Klett DE; Sood A; Sammon JD; Pucheril D; Dalela D; Diaz M; Peabody JO; Trinh QD; Menon M
    BJU Int; 2015 Nov; 116(5):703-12. PubMed ID: 25413443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil.
    Silva TB; Oliveira CZ; Faria EF; Mauad EC; Syrjänen KJ; Carvalho AL
    Anticancer Res; 2015 May; 35(5):2881-6. PubMed ID: 25964571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Predictive models for biochemical recurrence of prostate cancer after local treatment. Nomograms].
    Fernando AB; Escaño LM; Saiz GS; Sanz LA
    Arch Esp Urol; 2012; 65(1):39-50. PubMed ID: 22318176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
    Wang SY; Cowan JE; Cary KC; Chan JM; Carroll PR; Cooperberg MR
    BJU Int; 2014 Dec; 114(6b):E18-E24. PubMed ID: 24712895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.